Junzhang Chen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Junzhang Chen

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Bioengineered|April 18, 2022

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinomaYongyu Yang, Lei Gao, Junzhang Chen, et al.

Journal of Immunology Research|November 21, 2022

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular CarcinomaYongyu Yang, Wang Xiao, Ruoqi Liu, et al.

International Journal of Nanomedicine|March 11, 2024

Drug-Loaded Tumor-Derived Microparticles Elicit CD8+ T Cell-Mediated Anti-Tumor Response in Hepatocellular CarcinomaYulin Chen, Yi Zhang, Jianjun Wang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Bioengineered|April 18, 2022

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinomaYongyu Yang, Lei Gao, Junzhang Chen, et al.

Journal of Immunology Research|November 21, 2022

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular CarcinomaYongyu Yang, Wang Xiao, Ruoqi Liu, et al.

International Journal of Nanomedicine|March 11, 2024

Drug-Loaded Tumor-Derived Microparticles Elicit CD8+ T Cell-Mediated Anti-Tumor Response in Hepatocellular CarcinomaYulin Chen, Yi Zhang, Jianjun Wang, et al.

Pageof 2